CLINICAL TRIALS PROFILE FOR STRENSIQ
✉ Email this page to a colleague
All Clinical Trials for STRENSIQ
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT02797821 ↗ | Pharmacokinetic and Dose Response Study of Asfotase Alfa in Adult Patients With Pediatric-Onset Hypophosphatasia (HPP) | Completed | Alexion Pharmaceuticals | Phase 2 | 2016-06-06 | The purpose of this study was to evaluate the pharmacokinetics (PK) and pharmacodynamics (PD) of asfotase alfa in adult participants with pediatric-onset HPP. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for STRENSIQ
Condition Name
Clinical Trial Locations for STRENSIQ
Trials by Country
Clinical Trial Progress for STRENSIQ
Clinical Trial Phase
Clinical Trial Sponsors for STRENSIQ
Sponsor Name